James M. Daly - Insider Trading & Ownership

Location
Incyte Corporation Experimental Station, Rte 141 & Henry Clay Rd. Bldg E336, Wilmington, DE
Summary
The estimated net worth of James M. Daly is at least $2.04M dollars as of November 12, 2025. James M. Daly is the Director of HALOZYME THERAPEUTICS, INC. and owns shares of HALOZYME THERAPEUTICS, INC. (HALO) stock worth about $896K. James M. Daly is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $877K. James M. Daly is the Director of ACADIA PHARMACEUTICALS INC and owns shares of ACADIA PHARMACEUTICALS INC (ACAD) stock worth about $249K. James M. Daly is the Director of BELLICUM PHARMACEUTICALS, INC and owns shares of BELLICUM PHARMACEUTICALS, INC stock worth about $21.6K.
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of James M. Daly

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HALO HALOZYME THERAPEUTICS, INC. Director $896K Aug 11, 2023
MDGL MADRIGAL PHARMACEUTICALS, INC. Director $877K -$5.38M -86% Jun 20, 2025
ACAD ACADIA PHARMACEUTICALS INC Director $249K -$671K -72.9% Nov 10, 2025
BLCM BELLICUM PHARMACEUTICALS, INC Director $21.6K Jan 3, 2023
CYTK CYTOKINETICS INC Director Aug 19, 2025

Insider Transactions Reported by James M. Daly:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.